| (Values in U.S. Thousands) | Jul, 2024 | Jul, 2023 | Jul, 2022 | Jul, 2021 | Mar, 2021 |
| Sales | 2,331 | 1,030 | 1,071 | 0 | 0 |
| Sales Growth | +126.32% | -3.81% | unch | unch | unch |
| Net Income | -2,052 | -2,390 | -10,496 | -3,867 | -291 |
| Net Income Growth | +14.17% | +77.23% | -171.41% | -1,230.55% | -145.67% |
Universal Ibogaine Inc (IBO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.
Fiscal Year End Date: 07/31